Although the P2X7 receptor has been suggested previously as a promising target candidate for therapies in severe pulmonary TB (Amaral et al., 2014), our present findings provide proof of concept for this approach in mice infected with hypervirulent mycobacteria. Here, P2RX7 is linked to pulmonary tuberculosis.